Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
Condition(s) studied
Investigational drug(s) / intervention(s)
Five Digits Test: Neuropsychological test of Inhibition
Study summary
Neuropsychiatric conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and autism are characterized by specific deficits in cognitive functions. Thus, neuropsychological assessment is a critical part of the diagnostic process for these conditions. Inhibition is a specific function of interest during these examinations, since it is often affected in patients with ADHD and/or autism. The Five Digits Test (FDT) is a newly developed test measuring inhibition, without requirements of reading ability, and only limited requirements of language proficiency.
The aim of this study is to investigate the validity of the FDT in patients with neuropsychiatric conditions. The FDT will be validated using the following research questions:
1. Is the FDT equivalent to the standard neuropsychological test of inhibition, the Color-Word Interference Test from the Delis-Kaplan Executive Function System in patients with neuropsychiatric conditions? (Convergent validity)
2. Is the FDT consistent with self-assessment of inhibition and behavioral regulation in every day life using the Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A)? (Ecological validity)
3. Are there differences in validity in the first two research questions due to language background or due to reading and writing difficulties?
4. Are there differences between patients with neuropsychiatric conditions and healthy controls in the performance of the FDT?
Eligibility
Primary outcome measure(s)
- Convergent validity of the Five Digits Test — Baseline
The results of the Five Digits Test will be validated against the test Color-Word Interference Test from Delis-Kaplan Executive Functions system. The validation will be performed by calculation of the correlation coefficient (Pearson or Spearman) between these tests. Time to completion will be used as outcome in both tests, where slower times indicate lower performance.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Umeå University, Umeå University Hospital | Umeå | Sweden | Recruiting |
More Umeå University trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07531914 on ClinicalTrials.gov ↗ ← All trials in Sweden